TTP Group opens Pharmaplan branch in Stein, CH
©2022 Pharmaplan AG
With Novartis opening the production site in 2021, a wide range of companies from the life science sector are expected to settle there. The chemical and pharmaceutical group Lonza has already been represented in Stein since 2019, the biotechnology company Celonic since the beginning of 2021. Pharmaplan has been active in Stein for more than 10 years and possesses core competencies that are in demand in many areas. The new branch also gives Pharmaplan a decisive strategic advantage to secure its position as Swiss market leader.
Project Manager and Portfolio Manager Francis Hartmann has been familiar with the site in his role for many years in numerous projects: "With the new office, we are directly on-site as the engineering partner for the entire campus. Thanks to our site-specific know-how, we can provide Novartis, Lonza, Celonic, and future pharmaceutical and biotech companies with targeted and rapid planning and construction of their production and research capacities, while also supporting our customers with our extensive site engineering service portfolio in all areas."
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.